Track your nutrition and health goals

By Dr. Sumedha Verma | Medically Reviewed | Updated May 2026
Non-HDL cholesterol is a number that increasingly appears on lipid profile reports in India, and many people don't know what to do with it.
Your doctor might have flagged it; your lab report might show it as a calculated value; you might have seen it in range tables but never had it explained.
Non-HDL is not a new discovery. It has been present in cardiology research for decades, and major guidelines from the American Heart Association, the European Society of Cardiology, and the Indian guidelines for dyslipidemia management all now recommend Non-HDL as a primary treatment target — in some cases, ahead of LDL.
Here's what it is, why it matters, and what to do when it's elevated.
Non-HDL cholesterol is the total amount of cholesterol carried in all atherogenic (artery-clogging) lipoproteins in your blood. It is calculated by a simple subtraction:
Non-HDL Cholesterol = Total Cholesterol − HDL Cholesterol
The reason this matters is that LDL is not the only atherogenic particle in your blood. Your blood also contains:
A standard LDL measurement captures only LDL cholesterol. Non-HDL captures cholesterol from LDL + VLDL + IDL + Lp(a) — all the particles that contribute to atherosclerosis. This makes it a more comprehensive measure of atherogenic burden.
The conventional lipid panel focuses heavily on LDL. But LDL has two limitations as a sole risk predictor:
LDL can be falsely low with high triglycerides. LDL is usually calculated using the Friedewald equation, which becomes inaccurate when triglycerides are above 200 mg/dL. In this situation, calculated LDL underestimates the true amount of atherogenic cholesterol. Non-HDL, being a direct subtraction, is not affected by triglyceride levels.
People with high triglycerides carry significant VLDL-cholesterol that LDL doesn't capture. Someone with triglycerides of 300 mg/dL has approximately 60 mg/dL of VLDL cholesterol circulating — a substantial atherogenic load that wouldn't appear in the LDL number.
Studies consistently show that Non-HDL predicts cardiovascular events at least as well as LDL, and better than LDL in people with elevated triglycerides or metabolic syndrome. Since both these conditions are extremely prevalent in India, Non-HDL is particularly relevant for Indian patients.
| Category | Non-HDL Level |
|---|---|
| Optimal | Below 130 mg/dL |
| Near optimal | 130–159 mg/dL |
| Borderline high | 160–189 mg/dL |
| High | 190–219 mg/dL |
| Very high | 220 mg/dL and above |
Non-HDL targets are set 30 mg/dL higher than LDL targets in most guidelines, because Non-HDL includes VLDL and IDL in addition to LDL. For example:
| Clinical situation | LDL target | Non-HDL target |
|---|---|---|
| Low cardiovascular risk | <130 mg/dL | <160 mg/dL |
| Moderate risk | <100 mg/dL | <130 mg/dL |
| High risk (diabetes, hypertension + multiple risk factors) | <70 mg/dL | <100 mg/dL |
| Very high risk (established CVD) | <55 mg/dL | <85 mg/dL |
You can calculate your Non-HDL directly from your lipid profile report:
Non-HDL = Total Cholesterol − HDL
Example 1:
Example 2:
Example 3:
High Non-HDL is caused by any combination of high LDL, high VLDL, and high IDL. The underlying drivers include:
High LDL drivers: Saturated fat intake (ghee, butter, full-fat dairy, red meat), trans fats (vanaspati, packaged fried foods), genetic hypercholesterolaemia, hypothyroidism, chronic kidney disease.
High VLDL/triglyceride drivers: Excess refined carbohydrates (white rice, maida, sugar), alcohol, physical inactivity, abdominal obesity, insulin resistance, type 2 diabetes.
Both LDL and VLDL are elevated together (mixed dyslipidemia): This is the most common pattern in India and produces the highest Non-HDL values. The cause is usually a combination of dietary saturated fat + refined carbohydrates + physical inactivity.
Low HDL simultaneously worsens Non-HDL: if HDL is low, Non-HDL can be elevated even when total cholesterol appears normal.
Both. LDL is the primary treatment target in most clinical guidelines and the number most doctors reference. Non-HDL should be tracked when:
For most people with standard dyslipidemia (high LDL, normal triglycerides), LDL tracking is sufficient. For people with mixed dyslipidemia, Non-HDL is a more meaningful target.
Since Non-HDL = LDL + VLDL + IDL, lowering Non-HDL requires reducing both LDL and triglycerides (VLDL).
To lower the LDL component:
To lower the VLDL/triglyceride component:
To raise HDL (which directly improves Non-HDL by increasing the subtracted amount):
Medical treatment: Statins lower both LDL and VLDL modestly — making them effective for Non-HDL reduction. For high VLDL/triglyceride-driven Non-HDL, fibrates or omega-3 prescription supplements may be added. Combination therapy (statin + fibrate or statin + omega-3) is used when both LDL and triglycerides are significantly elevated.
If your Non-HDL cholesterol is elevated — especially in the context of high triglycerides or low HDL — a personalised dietary plan targeting your specific lipid pattern makes a significant difference. The Hint app provides condition-specific dyslipidemia diet plans through Hint Pro and Hint Premium.
What is non-HDL cholesterol? Non-HDL cholesterol is the total cholesterol in all atherogenic (artery-clogging) lipoproteins: LDL + VLDL + IDL. It is calculated as Total Cholesterol − HDL. Unlike LDL, which only measures one type of harmful particle, Non-HDL captures the full atherogenic burden in the blood.
What is a normal non-HDL cholesterol level? The optimal Non-HDL is below 130 mg/dL. Near optimal is 130–159 mg/dL. Borderline high is 160–189 mg/dL. Above 190 mg/dL is high. Targets differ by cardiovascular risk level — for people with diabetes or existing heart disease, the target is below 100 mg/dL.
How do I calculate non-HDL cholesterol? Non-HDL = Total Cholesterol − HDL Cholesterol. Both numbers appear on a standard lipid profile report. Example: if your total cholesterol is 215 mg/dL and HDL is 48 mg/dL, your Non-HDL is 215 − 48 = 167 mg/dL (borderline high).
Why is non-HDL better than LDL for assessing heart risk? Non-HDL captures all atherogenic lipoprotein cholesterol (LDL + VLDL + IDL + Lp(a)), while LDL only captures one fraction. When triglycerides are elevated (which is common in India), LDL calculated using the Friedewald equation is inaccurate — Non-HDL remains reliable. Studies consistently show that Non-HDL predicts cardiovascular events as well as or better than LDL in people with metabolic syndrome or diabetes.
What causes high non-HDL cholesterol? High Non-HDL is caused by elevated LDL (driven by saturated fat, genetics, hypothyroidism), elevated VLDL/triglycerides (driven by refined carbohydrates, alcohol, physical inactivity, obesity, diabetes), or both together (mixed dyslipidemia). Low HDL worsens Non-HDL even when total cholesterol is borderline.
How do I lower non-HDL cholesterol? Reduce both LDL and triglycerides simultaneously: cut saturated fat and refined carbohydrates, eliminate alcohol, switch to mustard oil or rice bran oil, add omega-3 foods (fatty fish, flaxseeds), increase aerobic exercise, and lose abdominal weight if overweight. If lifestyle changes are insufficient, statins reduce Non-HDL effectively; fibrates are added for high triglyceride-driven Non-HDL.
Dr. Sumedha Verma is a Consultant Physician at Clearcals with extensive experience in clinical medicine and healthcare services.
She has significant expertise in managing chronic conditions such as fatty liver, diabetes, thyroid disorders, PCOS, infertility, and other gynecological health concerns.
Known for her patient-centered approach, Dr. Verma focuses on improving patient compliance and helping individuals achieve better health outcomes through personalized medical guidance and long-term care.
🔗 Connect with Dr. Sumedha on LinkedIn